Cefuroxime Injection Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

cefuroxime injection

novartis new zealand ltd - cefuroxime sodium 1577.8mg equivalent to cefuroxime 1500 mg - powder for injection - 1.5 g - active: cefuroxime sodium 1577.8mg equivalent to cefuroxime 1500 mg

Cefuroxime Injection Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

cefuroxime injection

novartis new zealand ltd - cefuroxime sodium 263mg equivalent to cefuroxime 250 mg - powder for injection - 250 mg - active: cefuroxime sodium 263mg equivalent to cefuroxime 250 mg

Cefuroxime Injection Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

cefuroxime injection

novartis new zealand ltd - cefuroxime sodium 788.9mg equivalent to cefuroxime 750 mg - powder for injection - 750 mg - active: cefuroxime sodium 788.9mg equivalent to cefuroxime 750 mg

Zinacef Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

zinacef

glaxosmithkline nz limited - cefuroxime sodium 789mg equivalent to 750 mg cefuroxime;  ;   - powder for injection - 750 mg - active: cefuroxime sodium 789mg equivalent to 750 mg cefuroxime     - cefuroxime is a bactericidal cephalosporin antibiotic which is resistant to most ?-lactamases and is active against a wide range of gram-positive and gram-negative organisms. it is indicated for the treatment of infections before the infecting organism has been identified or when caused by sensitive bacteria. susceptibility to cefuroxime sodium will vary with geography and time and local susceptibility data should be consulted where available. indications include - respiratory tract infections for example, acute exacerbation of chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess and post-operative chest infections. - ear, nose and throat infections for example, sinusitis, tonsillitis, pharyngitis and otitis media. - urinary tract infections for example, acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria. - soft-tissue infections for example, cellulitis, erysipelas and wound infections. - bone and joint infections for example, osteomyelitis and septic arthritis. - obstetric and gynaecological infections, pelvic inflammatory diseases. - gonorrhoea particularly when penicillin is unsuitable. - other infections including septicaemia, meningitis and peritonitis. - prophylaxis against infection in abdominal, pelvic, orthopaedic, cardiac, pulmonary, oesophageal and vascular surgery where there is increased risk from infection.

Cefuroxime 1.5 g Powder for Injection/Infusion Irland - engelska - HPRA (Health Products Regulatory Authority)

cefuroxime 1.5 g powder for injection/infusion

flynn pharma limited - cefuroxime sodium - powder for solution for injection/infusion - 1.5 gram(s) - second-generation cephalosporins; cefuroxime

Cefuroxime 750 mg Powder for Injection/Infusion Irland - engelska - HPRA (Health Products Regulatory Authority)

cefuroxime 750 mg powder for injection/infusion

flynn pharma limited - cefuroxime sodium - powder for solution for injection/infusion - 750 milligram(s) - second-generation cephalosporins; cefuroxime

Cefuroxime 250 mg Powder for solution for injection Irland - engelska - HPRA (Health Products Regulatory Authority)

cefuroxime 250 mg powder for solution for injection

stravencon ltd - cefuroxime sodium - powder for solution for injection - 250 milligram(s) - second-generation cephalosporins; cefuroxime